For estradiol (E2) the separation of the degradation products 6- and 9,11-E2 is especially challenging due to their structural similarity. There is no method described in the literature yet which adequately addresses this problem. The present study describes a HPLC method for the separation and quantitation of E2 and its degradation products 6α-hydroxy-E2, 6β-hydroxy-E2, 6-keto-E2, Δ9,11-E2, β-equilenol and Δ6-E2. The method employs a KinetexTM PFP analytical column, using methanol and deionized water as mobile phases. Different UV- and fluorescence detection modes were used for maximal sensitivity and specificity. The applicability and capability of the method was demonstrated for Vagifem® tablets. Finally, the method was validated with respect to selectivity, sensitivity, linearity, precision and accuracy.
No takes yet. Share an insight, caveat, or question.
Schulz et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: